| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 85.23B | 84.31B | 77.99B | 77.30B | 73.42B | 74.19B |
| Gross Profit | 27.14B | 26.88B | 32.88B | 31.62B | 32.20B | 30.93B |
| EBITDA | 24.87B | 24.51B | 23.48B | 22.11B | 22.17B | 21.42B |
| Net Income | 12.82B | 12.40B | 12.13B | 10.85B | 10.66B | 10.52B |
Balance Sheet | ||||||
| Total Assets | 118.08B | 118.27B | 115.57B | 119.65B | 118.61B | 112.18B |
| Cash, Cash Equivalents and Short-Term Investments | 3.43B | 3.51B | 3.16B | 3.26B | 3.19B | 3.10B |
| Total Debt | 18.00M | 10.00M | 43.00M | 106.00M | 198.00M | 308.00M |
| Total Liabilities | 17.54B | 19.07B | 18.09B | 18.53B | 18.42B | 17.80B |
| Stockholders Equity | 97.73B | 96.54B | 95.09B | 98.88B | 96.42B | 91.03B |
Cash Flow | ||||||
| Free Cash Flow | 7.52B | 9.53B | 1.76B | 6.66B | 10.49B | 9.57B |
| Operating Cash Flow | 13.70B | 15.09B | 11.33B | 14.64B | 18.77B | 19.07B |
| Investing Cash Flow | -3.02B | -3.57B | 4.91B | -3.94B | -13.82B | -13.11B |
| Financing Cash Flow | -10.47B | -11.17B | -16.35B | -10.63B | -4.85B | -6.24B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥268.47B | 20.92 | 13.42% | 2.27% | 5.10% | 12.48% | |
76 Outperform | ¥10.14T | 14.84 | 13.75% | 2.85% | 3.34% | 20.36% | |
73 Outperform | ¥13.56T | 12.68 | 10.59% | 3.36% | 2.10% | -9.29% | |
71 Outperform | ¥488.60B | 21.33 | 15.67% | 1.31% | 12.48% | 18.38% | |
66 Neutral | ¥416.66B | 24.52 | 17.97% | 1.36% | 4.75% | 17.02% | |
64 Neutral | ¥10.21T | 18.84 | ― | 3.99% | 7.79% | 5.53% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% |